Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert F Jacob

Showing results (1-10 of 36) with videos related to

Pageof 4
Sort By:
The Journal of Biological Chemistry|October 1, 2005
Lipid peroxidation induces cholesterol domain formation in model membranesRobert F Jacob, R Preston Mason
Biochimica Et Biophysica Acta|December 3, 2014
Eicosapentaenoic acid inhibits glucose-induced membrane cholesterol crystalline domain formation through a potent antioxidant mechanismR Preston Mason, Robert F Jacob
Current Cardiology Reports|September 3, 2010
Advances in pharmacologic modulation of nitric oxide in hypertensionYoshiko Mizuno, Robert F Jacob, R Preston Mason
American Journal of Hypertension|August 30, 2008
Effects of calcium channel and renin-angiotensin system blockade on intravascular and neurohormonal mechanisms of hypertensive vascular diseaseYoshiko Mizuno, Robert F Jacob, R Preston Mason
The American Journal of Cardiology|June 24, 2008
Biologic activity of carotenoids related to distinct membrane physicochemical interactionsHyesun McNulty, Robert F Jacob, R Preston Mason
Coronary Artery Disease|July 9, 2004
The antioxidant effects of statinsJean Davignon, Robert F Jacob, R Preston Mason
Biochimica Et Biophysica Acta|March 22, 2003
Direct evidence for cholesterol crystalline domains in biological membranes: role in human pathobiologyR Preston Mason, Thomas N Tulenko, Robert F Jacob
Circulation|June 3, 2004
Effects of HMG-CoA reductase inhibitors on endothelial function: role of microdomains and oxidative stressR Preston Mason, Mary F Walter, Robert F Jacob
Journal of Cardiovascular Pharmacology|March 6, 2016
Eicosapentaenoic Acid Inhibits Oxidation of ApoB-containing Lipoprotein Particles of Different Size In Vitro When Administered Alone or in Combination With Atorvastatin Active Metabolite Compared With Other Triglyceride-lowering AgentsR Preston Mason, Samuel C R Sherratt, Robert F Jacob
Sub-Cellular Biochemistry|July 7, 2007
A biological rationale for the cardiotoxic effects of rofecoxib: comparative analysis with other COX-2 selective agents and NSAidsR Preston Mason, Mary F Walter, Charles A Day, et al.
Pageof 4

Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
The Journal of Biological Chemistry|October 1, 2005
Lipid peroxidation induces cholesterol domain formation in model membranesRobert F Jacob, R Preston Mason
Biochimica Et Biophysica Acta|December 3, 2014
Eicosapentaenoic acid inhibits glucose-induced membrane cholesterol crystalline domain formation through a potent antioxidant mechanismR Preston Mason, Robert F Jacob
Current Cardiology Reports|September 3, 2010
Advances in pharmacologic modulation of nitric oxide in hypertensionYoshiko Mizuno, Robert F Jacob, R Preston Mason
American Journal of Hypertension|August 30, 2008
Effects of calcium channel and renin-angiotensin system blockade on intravascular and neurohormonal mechanisms of hypertensive vascular diseaseYoshiko Mizuno, Robert F Jacob, R Preston Mason
The American Journal of Cardiology|June 24, 2008
Biologic activity of carotenoids related to distinct membrane physicochemical interactionsHyesun McNulty, Robert F Jacob, R Preston Mason
Coronary Artery Disease|July 9, 2004
The antioxidant effects of statinsJean Davignon, Robert F Jacob, R Preston Mason
Biochimica Et Biophysica Acta|March 22, 2003
Direct evidence for cholesterol crystalline domains in biological membranes: role in human pathobiologyR Preston Mason, Thomas N Tulenko, Robert F Jacob
Circulation|June 3, 2004
Effects of HMG-CoA reductase inhibitors on endothelial function: role of microdomains and oxidative stressR Preston Mason, Mary F Walter, Robert F Jacob
Journal of Cardiovascular Pharmacology|March 6, 2016
Eicosapentaenoic Acid Inhibits Oxidation of ApoB-containing Lipoprotein Particles of Different Size In Vitro When Administered Alone or in Combination With Atorvastatin Active Metabolite Compared With Other Triglyceride-lowering AgentsR Preston Mason, Samuel C R Sherratt, Robert F Jacob
Sub-Cellular Biochemistry|July 7, 2007
A biological rationale for the cardiotoxic effects of rofecoxib: comparative analysis with other COX-2 selective agents and NSAidsR Preston Mason, Mary F Walter, Charles A Day, et al.
Pageof 4